EXPRESS SCRIPTS
LIVE

Serial Number

87585041

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Oct 1, 1986

Filing Date

Aug 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

EXPRESS SCRIPTS Trademark

Serial Number: 87585041 • Registration: 5830923

EXPRESS SCRIPTS is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on August 26, 2017. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

August 26, 2017

Registration Date

August 13, 2019

First Use Anywhere

October 1, 1986

First Use in Commerce

October 1, 1986

Published for Opposition

May 28, 2019

Goods & Services

Pharmacy benefit management services; pharmacy benefit management consulting services; medical benefit management services; advisory services and consultancy regarding healthcare benefits and pharmacy benefits; provision of information and analysis in the fields of healthcare benefits and pharmacy benefits; medicare prescription coverage plans services, namely, providing insurance underwriting and claims administration of medicare prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans; pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify potential cost savings and for clinical benefits; pharmacy benefit management services for organized labor

Drug utilization review services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; market analysis and reporting of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers; conducting and arranging business conferences in the field of pharmacy benefit management

Advisory services and consultancy regarding healthcare; Healthcare services, namely, wellness and disease management programs; medicare prescription coverage plan services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, and providing information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare, pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 6, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 6, 2025 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 6, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 2, 2025 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2024 REAP
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 13, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2019 R.PR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2019 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 24, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2019 CRFA
ASSIGNED TO LIE
Apr 18, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 9, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 9, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 9, 2018 GNRN
NON-FINAL ACTION E-MAILED
Oct 9, 2018 GNRT
NON-FINAL ACTION WRITTEN
Oct 9, 2018 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 8, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 7, 2018 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 22, 2018 GNFN
FINAL REFUSAL E-MAILED
Jun 22, 2018 GNFR
FINAL REFUSAL WRITTEN
Jun 22, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 13, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 7, 2017 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 26, 2017 PREV
ASSIGNED TO LIE
Oct 20, 2017 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 10, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 6, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 6, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 6, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 6, 2017 CNEA
ASSIGNED TO EXAMINER
Oct 4, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 31, 2017 NWOS
NEW APPLICATION ENTERED
Aug 30, 2017 NWAP